Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Glargine Insulin U-100	1,263
Overall Study	STARTED	Glimepiride	1,254
Overall Study	STARTED	Liraglutide	1,262
Overall Study	STARTED	Sitagliptin	1,268
Overall Study	COMPLETED	Glargine Insulin U-100	1,138
Overall Study	COMPLETED	Glimepiride	1,142
Overall Study	COMPLETED	Liraglutide	1,156
Overall Study	COMPLETED	Sitagliptin	1,144
Overall Study	NOT COMPLETED	Glargine Insulin U-100	125
Overall Study	NOT COMPLETED	Glimepiride	112
Overall Study	NOT COMPLETED	Liraglutide	106
Overall Study	NOT COMPLETED	Sitagliptin	124

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01794143/flow